3 results match your criteria: "Faculty of Health Sciences University of Cape Town and Groote Schuur Hospital[Affiliation]"
Health Sci Rep
February 2019
Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences University of Cape Town Cape Town South Africa.
Background: Cancer treatment in the 21st century has seen immense advances in optical imaging and immunotherapy. Significant progress has been made in the bioengineering and production of immunoconjugates to achieve the goal of specifically targeting tumors.
Discussion: In the 21st century, antibody drug conjugates (ADCs) have been the focus of immunotherapeutic strategies in cancer.
S Afr J Surg
March 2018
Cancer Research Initiative, Faculty of Health Sciences, University of Cape Town, Observatory 7925, South Africa. Women's Health Research Unit, School of Public Health & Family Medicine, Faculty of Health Sciences, University of Cape Town.
Colorectal cancer (CRC) is the third most common cancer worldwide and the fourth most common cause of cancer related deaths. It is estimated that CRC is amongst the top five malignancies in South Africa (SA) with an age standardised incidence rate of 10.2 and 6.
View Article and Find Full Text PDFBMJ Open
July 2017
Department of Medicine, Faculty of Health Sciences University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
Introduction: Latent tuberculosis infection (LTBI) remains a major public health problem and one of the major contributors to the pool of active tuberculosis cases. The true burden of LTBI in Africa is not known. Early modelling studies estimate that over 33% of the world's population is infected with latent tuberculosis.
View Article and Find Full Text PDF